Re: SP 52 week low
in response to
by
posted on
Oct 06, 2022 01:19PM
KBC - Take a look at the financials and MD&A's just before and after the $6 million loan. There wasn't much left for trials after taking care of outstandings and opp costs. You are correct about my guessing on the number of trial patients...just like you are. The shareholders are left to guess too much with most things RVX.
Have a great day.
tada